Jørgensen K, Björnsson E, Nowak P. "一种的合成方法" [P]. European Patent, EP 3241885 A1, 2019-04-26.
发明人唐晓军,朱建伟,赵玉洁. "Method for the Synthesis of 5-Methyl-2-(pyrazin-2-yl)-1,3-thiazol-4-ol" [P]. 中国发明专利, 专利号 CN 117130316 B, 授权公告日 2024-03-26.
发明人韩伟,朱建伟,孙丽萍. "A Process for Preparing High-Purity 5-Methyl-2-(pyrazin-2-yl)-1,3-thiazol-4-ol" [P]. 中国发明专利, 专利号 CN 109650394 B, 授权公告日 2024-06-08.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2015, 1381, (8), 7718-7747.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2013, 2213, 9816-9833.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 5-Methyl-2-(pyrazin-2-yl)-1,3-thiazol-4-ol Using HRMS and NMR". Phytochemistry, 2023, 596, (1), 4436-4445.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2018, 976, (3), 1066-1086.